ARCHIVES

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

High-Dose Chemo Can Cure Rare Pediatric Brain Tumor

February 25, 2005

NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13

April 1, 1994

AACR Grant Programs. NIH RFA Available.

June 29, 2001

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

September 3, 2010

Youth Smoking Begins To Decline, NCI Says

April 5, 2002

AACR honors Emil Frei III for pioneering work in childhood leukemia.

April 2, 2004